Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18502 | 27087367 | Sci Rep | Sexually Dimorphic Expression of eGFP Transgene in the Akr1A1 Locus of Mouse Liver Regulated by Sex Hormone-Related Epigenetic Remodeling. | 2016 | Details |
| A18503 | 27086596 | J Pathol Transl Med | Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18504 | 27086005 | Curr Gastroenterol Rep | Pediatric Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A18505 | 27085971 | Biochim Biophys Acta | BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity. | 2016 | Details |
| A18506 | 27085785 | Metabolism | Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2015 | Details |
| A18507 | 27085779 | Metabolism | Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A18508 | 27085774 | Metabolism | Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity. | 2016 | Details |
| A18509 | 27085070 | Biochim Biophys Acta | Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. | 2016 | Details |
| A18510 | 27083512 | J Gastroenterol Hepatol | Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. | 2017 | Details |
| A18511 | 27083404 | Obes Res Clin Pract | Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity. | 2016 | Details |
| A18512 | 27081834 | Mol Med Rep | Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro. | 2016 | Details |
| A18513 | 27079922 | Sci Rep | Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18514 | 27077854 | Int J Mol Sci | Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. | 2016 | Details |
| A18515 | 27077736 | PLoS One | Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18516 | 27076897 | Int J Prev Med | The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial. | 2016 | Details |
| A18517 | 27076758 | World J Gastroenterol | Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease. | 2016 | Details |
| A18518 | 27076501 | Hum Reprod | Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. | 2016 | Details |
| A18519 | 27075683 | Sci Rep | A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. | 2016 | Details |
| A18520 | 27075663 | BMC Pharmacol Toxicol | Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats. | 2016 | Details |
| A18521 | 27074921 | Dig Dis Sci | Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. | 2016 | Details |
| A18522 | 27074850 | Hepatol Int | Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. | 2016 | Details |
| A18523 | 27073470 | Exp Ther Med | Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease. | 2016 | Details |
| A18524 | 27072576 | Oncotarget | Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. | 2016 | Details |
| A18525 | 27069915 | Biomed Res Int | A Recipe Composed of Chinese Herbal Active Components Regulates Hepatic Lipid Metabolism of NAFLD In Vivo and In Vitro. | 2016 | Details |
| A18526 | 27069901 | Prev Nutr Food Sci | Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats. | 2016 | Details |
| A18527 | 27069868 | Mol Metab | Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. | 2016 | Details |
| A18528 | 27068982 | Biochem Soc Trans | Blood triacylglycerols: a lipidomic window on diet and disease. | 2016 | Details |
| A18530 | 30288302 | Hepatol Med Policy | Editor-in-Chief's welcome to Hepatology, Medicine and Policy. | 2016 | Details |
| A18531 | 27065733 | Ann Gastroenterol | The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking. | 2016 | Details |
| A18532 | 27064133 | Liver Int | Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up. | 2016 | Details |
| A18533 | 27063959 | Transl Res | Interleukin-18-deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis. | 2016 | Details |
| A18534 | 27063723 | Anal Sci | Imaging Mass Spectrometry Reveals a Decrease of Cardiolipin in the Kidney of NASH Model Mice. | 2016 | Details |
| A18536 | 27063277 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and Liver Transplantation. | 2016 | Details |
| A18537 | 27063276 | Clin Liver Dis | Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18538 | 27063275 | Clin Liver Dis | Emerging Therapies for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18539 | 27063274 | Clin Liver Dis | Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18540 | 27063273 | Clin Liver Dis | Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18541 | 27063272 | Clin Liver Dis | The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A18542 | 27063271 | Clin Liver Dis | Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. | 2015 | Details |
| A18543 | 27063270 | Clin Liver Dis | Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. | 2015 | Details |
| A18544 | 27063269 | Clin Liver Dis | Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18545 | 27063268 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and the Gut Microbiome. | 2015 | Details |
| A18546 | 27063267 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance. | 2016 | Details |
| A18547 | 27063266 | Clin Liver Dis | The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. | 2015 | Details |
| A18548 | 27063265 | Clin Liver Dis | The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities. | 2016 | Details |
| A18549 | 27063264 | Clin Liver Dis | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. | 2015 | Details |
| A18551 | 27062203 | Intern Med J | Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? | 2016 | Details |
| A18552 | 27061435 | J Cell Mol Med | miR-149 controls non-alcoholic fatty liver by targeting FGF-21. | 2016 | Details |
| A18553 | 27061197 | Aliment Pharmacol Ther | Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis. | 2016 | Details |
| A18554 | 28702244 | Clin Diabetes Endocrinol | Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus. | 2016 | Details |
| A18555 | 27060337 | J Thromb Haemost | Role of hemostatic factors in hepatic injury and disease: animal models de-liver. | 2016 | Details |
| A18556 | 27060021 | Clin Nutr | Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. | 2016 | Details |
| A18557 | 27059980 | Dig Dis Sci | APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. | 2016 | Details |
| A18558 | 27057890 | Medicine (Baltimore) | Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD. | 2016 | Details |
| A18559 | 27057275 | Oxid Med Cell Longev | Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis. | 2016 | Details |
| A18560 | 27057272 | Oxid Med Cell Longev | Aging Increases Susceptibility to High Fat Diet-Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. | 2016 | Details |
| A18563 | 27055973 | J Clin Lipidol | Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. | 2016 | Details |
| A18564 | 27055959 | J Clin Lipidol | The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. | 2015 | Details |
| A18566 | 27054361 | Obes Facts | Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study. | 2016 | Details |
| A18567 | 27054009 | Electron Physician | Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance. | 2016 | Details |
| A18568 | 27053858 | World J Gastroenterol | Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. | 2016 | Details |
| A18570 | 27053232 | Diabetologia | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate? | 2016 | Details |
| A18573 | 27052013 | Dig Dis Sci | Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18574 | 27051672 | Biomed Res Int | Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis. | 2016 | Details |
| A18575 | 27051596 | BBA Clin | Implication of hepatokines in metabolic disorders and cardiovascular diseases. | 2016 | Details |
| A18576 | 27051595 | BBA Clin | Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects. | 2016 | Details |
| A18577 | 27051590 | BBA Clin | Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese. | 2016 | Details |
| A18578 | 27049488 | Ann Hepatol | Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity. | 2017 | Details |
| A18579 | 27049380 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. | 2016 | Details |
| A18580 | 27049024 | J Lipid Res | Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis. | 2016 | Details |
| A18581 | 27048904 | Best Pract Res Clin Gastroenterol | Intestinal microbiota in liver disease. | 2016 | Details |
| A18582 | 27048250 | Diabetologia | Hepatic glucose and lipid metabolism. | 2016 | Details |
| A18583 | 27046953 | Yonago Acta Med | Components of Boiogito Suppress the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats. | 2016 | Details |
| A18584 | 27046482 | Clin Gastroenterol Hepatol | Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis. | 2016 | Details |
| A18585 | 27045862 | Sci Rep | Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies. | 2016 | Details |
| A18586 | 27045805 | Sci Rep | Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. | 2016 | Details |
| A18589 | 27044765 | Clin Mol Hepatol | The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. | 2016 | Details |
| A18590 | 27044324 | Biol Open | Trim37-deficient mice recapitulate several features of the multi-organ disorder Mulibrey nanism. | 2016 | Details |
| A18591 | 27043550 | Int J Mol Sci | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. | 2016 | Details |
| A18592 | 27043543 | Int J Mol Sci | Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. | 2016 | Details |
| A18593 | 27042666 | Biomed Res Int | Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study. | 2016 | Details |
| A18594 | 27042272 | J Diabetes Investig | New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort. | 2015 | Details |
| A18595 | 27041524 | Arch Iran Med | Effects of Synbiotics Supplementation in Lean Patients with Nonalcoholic Fatty Liver Disease: Study Protocol of a Pilot Randomized Double-blind Clinical Trial. | 2016 | Details |
| A18596 | 27041377 | Dig Dis Sci | Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A18597 | 27040510 | Biochim Biophys Acta | Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH. | 2016 | Details |
| A18598 | 27040343 | Yakugaku Zasshi | [A Future Perspective on the Involvement of n-3 Polyunsaturated Fatty Acid in the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis]. | 2016 | Details |
| A18599 | 27040342 | Yakugaku Zasshi | [Drug-induced Nonalcoholic Steatohepatitis]. | 2016 | Details |
| A18600 | 27040341 | Yakugaku Zasshi | [Incretin as a Novel Treatment Strategy for NAFLD/NASH]. | 2016 | Details |
| A18601 | 27040340 | Yakugaku Zasshi | [An Overview of NAFLD/NASH in Japan]. | 2016 | Details |
| A18603 | 27039224 | J Pediatr | Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. | 2016 | Details |
| A18604 | 27038703 | Dig Liver Dis | Non-alcoholic steatohepatitis and liver transplantation. | 2016 | Details |
| A18605 | 27038448 | Dig Dis Sci | Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. | 2016 | Details |
| A18608 | 27037502 | Int J Exp Pathol | Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet. | 2016 | Details |
| A18609 | 27036545 | BMC Pediatr | Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. | 2016 | Details |
| A18610 | 27036364 | Free Radic Biol Med | A Western diet induced NAFLD in LDLR(-/)(-) mice is associated with reduced hepatic glutathione synthesis. | 2016 | Details |
| A18611 | 27036035 | Oncotarget | Distinctly altered gut microbiota in the progression of liver disease. | 2016 | Details |
| A18612 | 27035833 | PLoS One | Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18613 | 27034174 | J Thromb Thrombolysis | Association between sleep condition and arterial stiffness in Chinese adult with nonalcoholic fatty liver disease. | 2016 | Details |
| A18614 | 27032902 | J Appl Physiol (1985) | Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease. | 2016 | Details |
| A18615 | 27032381 | J Hepatol | Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. | 2016 | Details |